Navigation Links
Neuro Kinetics Invited to Present at NIH Forum for Investors and Strategic Partners
Date:2/14/2012

PITTSBURGH, Feb. 14, 2012 /PRNewswire/ -- Neuro Kinetics, Inc. (NKI) (www.neuro-kinetics.com), manufacturers and marketers of noninvasive medical diagnostic equipment used worldwide for neurophysiologic/ neurotologic testing, said today that it is presenting at the National Institutes of Health's (NIH) Feedback Sessions in Washington D.C. on February 28, 2012.

The Feedback Sessions are an invitation only program funded by the NIH in cooperation with the Larta Institute (www.larta.org) called the SBIR Commercialization Assistance Program (CAP).  CAP exposes some of the nation's most promising small life science and healthcare companies and their technologies and business strategies to the investment community, strategic partners and licensees. 

NKI, with assistance from NIH and Larta, is presenting to investors, life science professionals and consultants, and corporate development officers at 8:30 Tuesday morning the 28th. 

"NKI is honored to be one of only forty companies selected to participate," said Vince Kytka, Director of Operations and Marketing. "This program is a great opportunity for accelerating our path to market."

NKI, poised for exciting growth, has had promising success with its I-Portal® technology to diagnose concussions, and, with the support of NIH's SBIR program, it is progressing in the development of its revolutionary I- Portal® Retinopathy product, a new, non-invasive ophthalmic diagnostic device. Initial data suggests this tool can provide early detection of diabetic retinopathy. 

"We are looking forward to this great opportunity to share our progress and potential with such a knowledgeable and influential group," added Howison Schroeder, President and CEO.

Admission to the sessions are limited and by invitation only. If you are interested in attending, please send your contact info to
'/>"/>

SOURCE Neuro Kinetics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Iron-moving malfunction may underlie neurodegenerative diseases, aging
2. Neurotechnology Releases SentiSight 2.0 SDK Universal Object Recognition Technology
3. Stabilizing force for good communication between neurons and muscle cells found
4. Researchers identify promising gene target for neuroblastoma therapy
5. How neuronal activity leads to Alzheimers protein cleavage
6. Mediator in communication between neurons and muscle cells found
7. 3-substituted indolones as novel therapeutic compounds for neurodegenerative conditions
8. A double-barreled immune cell approach for neuroblastoma
9. Protecting neurons could halt Alzheimers, Parkinsons diseases
10. Neuroinformatics special issue spotlights the Neuroscience Information Framework
11. Bipolar disorder genes, pathways identified by Indiana University neuroscientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... using tissue samples cultured from cystic fibrosis patients, scientists ... Marsico Lung Institute have shown that a new CF ... CF drug. , The finding, published today in the ... mutant CFTR protein becomes unstable and loses its ability ... two drugs. The research offers several insights into how ...
(Date:7/23/2014)... , , , , ... , , , , ... extend healthy lifespan. The idea, they argue, would be to target the... , , ... , , , , , ... , , , , , , , Medicine focuses almost ...
(Date:7/23/2014)... Roughly 780 million people around the world have no ... Health Organization (WHO), 3.4 million people die from water-related ... the goal of making a contribution to solving this ... Wendelin Stark, head of the Functional Materials Laboratory, the ... developing a prototype. , "What makes our DrinkPure filter ...
Breaking Biology News(10 mins):UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 2UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 3UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 4Strategy proposed for preventing diseases of aging 2Strategy proposed for preventing diseases of aging 3Strategy proposed for preventing diseases of aging 4Strategy proposed for preventing diseases of aging 5ETH student develops filter for clean water around the world 2
... Boston, MA (Jan. 18, 2012) The National ... Research Institute, a subsidiary of Mass. Eye and Ear, ... understand the origins of eye allergies (NEI Grant Number ... principal investigator for the project formally entitled "Cellular and ...
... new approach to motion capture technology is offering fresh ... general. Researchers studied three types of tennis serves, ... which creates the highest potential for shoulder injury. ... Annals of Biomedical Engineering , could aid sports training ...
... of microbiologists led by Indiana University researchers has identified a ... single end or pole of the cell instead of uniform, ... that could have implications in the development of new antibacterial ... bacteria such as Escherichia coli and Bacillus ...
Cached Biology News:Markerless motion capture offers a new angle on tennis injuries 2Markerless motion capture offers a new angle on tennis injuries 3Markerless motion capture offers a new angle on tennis injuries 4Polar growth at the bacterial scale reveals potential new targets for antibiotic therapy 2Polar growth at the bacterial scale reveals potential new targets for antibiotic therapy 3
(Date:7/23/2014)... made great strides in saving China,s endangered national treasure, ... 65 giant panda reserves that have been established and ... 1596 pandas remain in the wild. , Breeding ... the panda by improving genetic diversity, avoid inbreeding and ... are these high-profile programs doing so far? , In ...
(Date:7/23/2014)... Shimadzu Scientific Instruments has launched the ... developed jointly with Ajinomoto Co. Inc. Offering simultaneous ... amino acids in nine minutes, drastically enhancing laboratory ... utilizing a fast application-specific column and an LCMS-2020 ... even under conditions with difficult samples that contain ...
(Date:7/23/2014)... AVIV, Israel , July 23, 2014 /PRNewswire/ ... ., a portfolio company of Trendlines Agtech ... one of Israel,s leading ... http://photos.prnewswire.com/prnh/20140121/666259-a) , Valentis,s technology combines nanocrystalline ... plant pulp waste, with additional nanoparticles to produce ...
(Date:7/23/2014)... 2014  GrowBLOX Sciences, Inc. (OTCQB: GBLX), a medical cannabis ... for two medical marijuana dispensary locations in Las ... the Clark County, Nevada dispensary for ... previously announced.  GrowBLOX Sciences, CEO Craig Ellins ... applications for dispensaries in the City of Las ...
Breaking Biology Technology:Shimadzu's New UF-Amino Station Provides High-Speed, Multi-Component Analysis of Amino Acids in Food & Beverage and Pharmaceutical Testing 2Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2GrowBLOX Sciences, Inc. Files for Two Additional Medical Marijuana Dispensaries in Las Vegas 2GrowBLOX Sciences, Inc. Files for Two Additional Medical Marijuana Dispensaries in Las Vegas 3
... 3 ,HemoGenix(R) and ORF Genetics announce the collaboration ... for use in all HALO(R),Assay Kits and HALO(R) ... cells is detected. , ... of growth factors and cytokines using,barley seed as ...
... , QUEBEC CITY, Dec. ... AEZS ; TSX: AEZ), a global biopharmaceutical company focused ... completed the transaction under the previously announced purchase and ... relating to AEterna Zentaris, rights to royalties on future ...
... announces the exclusive licensing of DxS Scorpions™ technology to test for ... and targeted control of contaminant microbes can increase profitability. , ... ... ETS has had the exclusive license to use this technology in ...
Cached Biology Technology:HemoGenix(R), Inc Announces Implementation of ORF Genetics Human Growth Factors and Cytokines in All Human HALO(R) Assay Kits and Contract Research Services 2HemoGenix(R), Inc Announces Implementation of ORF Genetics Human Growth Factors and Cytokines in All Human HALO(R) Assay Kits and Contract Research Services 3AEterna Zentaris Closes Sale of Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners 2AEterna Zentaris Closes Sale of Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners 3ETS Laboratories Offers New Process Optimization Tools to the Fuel Ethanol Industry 2
Recorder, 6", 7 Day, 1 Pen, 0 to 100°C, 220V, 50/60 Hz, for 4520, Customer Installed...
... Serotec STAR3000 HISTAR detection systems ... to be used with species specific ... in tissue specimens. Visualisation is accomplished ... that utilises novel polymer labelling technology. ...
Taq DNA Polymerase (T. aquaticus), 250 units. For PCR and other procedures requiring DNA polymerase activity at elevated temperatures. Category: Nucleotides & Enzymes & Biochemicals, Modifying Enzyme...
... AmpliTaq DNA Polymerase is ... the PCR process, a testimony to its ... activity profile makes it ideal for PCR ... to guarantee reproducible results. ,, AmpliTaq ...
Biology Products: